Literature DB >> 34359552

Natural History of Untreated Retinoblastoma.

Junyang Zhao1, Zhaoxun Feng2, Brenda L Gallie3,4,5,6.   

Abstract

Treatment abandonment is a leading cause of death in children with retinoblastoma worldwide. We studied children who abandoned treatment upfront at diagnosis to delineate the natural history of untreated retinoblastoma. Studied were children who received no treatment, diagnosed between 2007 and 2017 at 29 Chinese centers. Data were retrospectively collected from medical chart reviews and interviews with each patient's family. During the study period, 44 children received no treatment after diagnosis of retinoblastoma. Clinical or radiologic evidence of orbital extension was available for 25 children, and radiologic evidence of systemic metastasis was available for 12 children. Median times from diagnosis of intraocular tumor to orbital disease was 13.7 months, orbital disease to metastasis was 2.6 months, and metastasis to death was 2.0 months. Children with brain metastasis had shorter survival than those with metastasis to other sites (median 1.0 vs. 3.1 months; p = 0.015). Overall, 36% of patients died within 12 months of diagnosis, 77% within 24 months, 95% within 36 months and 100% within 48 months. While multiple factors influence refusal of treatment, insights into the natural history of retinoblastoma derived from real-world evidence can inform clinicians and parents that retinoblastoma is life-threatening and encourage urgent treatment at diagnosis.

Entities:  

Keywords:  death; mortality; natural history; prognosis; retinoblastoma; treatment abandonment

Year:  2021        PMID: 34359552     DOI: 10.3390/cancers13153646

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  3 in total

1.  Anemia and Bone Marrow Suppression After Intra-Arterial Chemotherapy in Children With Retinoblastoma: A Retrospective Analysis.

Authors:  Changjuan Zeng; Minglei Han; Jiayan Fan; Xiaoyu He; Renbing Jia; Li Li; Xuyang Wen; Xuefei Song; Lili Hou
Journal:  Front Oncol       Date:  2022-07-25       Impact factor: 5.738

2.  The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries.

Authors: 
Journal:  Lancet Glob Health       Date:  2022-08       Impact factor: 38.927

3.  Retinoblastoma Survival Following Primary Enucleation by AJCC Staging.

Authors:  Junyang Zhao; Zhaoxun Feng; Gareth Leung; Brenda L Gallie
Journal:  Cancers (Basel)       Date:  2021-12-13       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.